跳转到主要内容
主页 / 资源 / 会议 / 9th Market Access, Pricing, & Reimbursement Global Congress
2nd Real-world Evidence World Congress Europe

9th Market Access, Pricing, & Reimbursement Global Congress
2nd Real-world Evidence World Congress Europe

9th Market Access, Pricing, & Reimbursement  Global Congress 2nd Real-world Evidence World Congress Europe

Sponsored Spotlight Sessions

European Collaboration on Health Technology Assessment – the New Road to Access

Elvira Müller, PhD

|

VP HTA and Evidence Development

Overview and key aspects | Status and timeline | EU joint HTA and national submissions | Challenges and implications

Leveraging Real-World Data during the COVID-19 Pandemic: The Dawn of a New Era for Real-World Evidence – Opportunities and Challenges

Stephane Read

|

Senior Epidemiologist

Robust RWE generation to accelerate drug approval and inform clinical practice during a rapidly evolving pandemic | COVID-19 and the wide-ranging role of RWE in informing decision making: From disease monitoring to treatment effectiveness | Methodological considerations and cautionary tales of RWE generation in COVID-19 | Best practices and lessons learned for effectively utilizing RWD/RWE in future pandemics

沪ICP备2022021526号

Powered by Translations.com GlobalLink OneLink Software